Literature DB >> 8046392

Comparison of cDNAs encoding the gibbon ape leukaemia virus receptor from susceptible and non-susceptible murine cells.

C A Wilson1, K B Farrell, M V Eiden.   

Abstract

The gibbon ape leukaemia virus (GaLV) family of type C retroviruses consists of five closely related viral isolates, GaLV SF, GaLV SEATO, GaLV Br, GaLV H and simian sarcoma-associated virus. The cDNA encoding the human receptor for GaLV SEATO had previously been isolated. We now demonstrate that all of the above GaLVs can use the human form of the GaLV receptor to infect cells. All murine cells analysed to date have been found to be resistant to infection by GaLVs owing to the absence of a functional GaLV receptor. We have now identified a murine cell line which is unique in its susceptibility to GaLV infection. This cell line was established from a Japanese feral mouse, Mus musculus molossinus. We cloned and sequenced the cDNA for the receptor expressed in these cells and compared it to the cDNA for the GaLV receptor expressed in resistant murine cells such as NIH 3T3 (derived from M. m. musculus) and MDTF (derived from M. dunni tail fibroblasts). The crucial region for GaLV infection (the fourth extracellular domain) from the functional M. m. molossinus GaLV receptor is quite divergent from the same region of the M. m. musculus and M. dunni proteins, but similar to that of the functional human GaLV receptor. These results confirm the importance of the amino acids of this region in GaLV receptor function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046392     DOI: 10.1099/0022-1317-75-8-1901

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor.

Authors:  C Salaün; P Rodrigues; J M Heard
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Extended analysis of the in vitro tropism of porcine endogenous retrovirus.

Authors:  C A Wilson; S Wong; M VanBrocklin; M J Federspiel
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Fungal phosphate transporter serves as a receptor backbone for gibbon ape leukemia virus.

Authors:  L Pedersen; M van Zeijl; S V Johann; B O'Hara
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Mutational analysis of the proposed gibbon ape leukemia virus binding site in Pit1 suggests that other regions are important for infection.

Authors:  G J Chaudry; M V Eiden
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.

Authors:  J Sugai; M Eiden; M M Anderson; N Van Hoeven; C D Meiering; J Overbaugh
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1.

Authors:  M D Lundorf; F S Pedersen; B O'Hara; L Pedersen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  A 13-amino-acid Pit1-specific loop 4 sequence confers feline leukemia virus subgroup B receptor function upon Pit2.

Authors:  K Dreyer; F S Pedersen; L Pedersen
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Characterization of hortulanus endogenous murine leukemia virus, an endogenous provirus that encodes an infectious murine leukemia virus of a novel subgroup.

Authors:  Christopher H Tipper; Craig E Bencsics; John M Coffin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

9.  Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells.

Authors:  C A Wilson; K B Farrell; M V Eiden
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.

Authors:  Adam S Lauring; Heather H Cheng; Maribeth V Eiden; Julie Overbaugh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.